The US Food and Drug Administration (FDA) is currently working to understand how cannabis and isolated CBD products can be useful to American citizens. There are robust statistics and stories emerging as the FDA conducts cannabis research. Read more about these details in the following stories, and sign up for our newsletter to be the first to find out when news hits the wire.
Tue / Jun 4th
The FDA’s first-ever CBD hearing took place last Friday. The agency heard from a host of speakers including nutritional supplement experts, private citizens, medical cannabis patients, hemp businesses, and more.
Thu / Apr 11th
The FDA last month warned three U.S. companies who were distributing hemp-derived CBD products that their products violate federal law.
Wed / Apr 3rd
The FDA is planning a public hearing next month to consider the safety, manufacturing, product quality, marketing, labeling, and sale of federally regulated CBD products.
Wed / Mar 6th
FDA Commissioner Dr. Scott Gottlieb, who just announced plans to create federal CBD regulations, now says he will retire next month.
Fri / Mar 1st
FDA Commissioner Dr. Scott Gotliebb is planning a meeting for public comment and testimony in April about creating a regulatory framework for CBD.
Wed / Dec 26th
FDA Commissioner Scott Gottlieb says the agency has started creating a regulatory framework for CBD products, which were legalized via the 2018 Farm Bill.
Tue / Nov 20th
U.S. Food and Drugs Administration (FDA) Commissioner Scott Gottlieb said in a CNBC interview on Friday that a federal cannabis… Read More
Thu / Nov 1st
The first FDA-approved medication containing cannabidiol (CBD) sourced from cannabis plants is now available by prescription in all 50 U.S.… Read More
Thu / Oct 18th
The FDA has received input from more than 2,000 individuals on the rescheduling of cannabis and other drugs just over… Read More
Wed / Oct 10th
FDA officials have put out a call for public comment about the potential rescheduling of cannabis and several other substances.… Read More
Tue / Oct 2nd
An FDA evaluation of CBD drug Epidiolex that was recently made public shows that the FDA originally wanted to make… Read More
Thu / Aug 9th
GW Pharmaceuticals has revealed the expected consumer price for Epidiolex, the first cannabidiol-based medication to be approved by the FDA,… Read More
Tue / Jul 17th
The California Department of Public Health’s Food and Drug Branch (CDPH-FDB) updated an FAQ last week to address food products… Read More
Mon / Jun 25th
The Food and Drug Administration approved GW Pharmaceuticals’ cannabidiol-based medication Epidiolex on Monday, according to the Washington Post. It is the… Read More
Fri / Apr 20th
Last week, Senate Majority Leader Mitch McConnell (R-KY) took to the chamber floor and laid out his case for the… Read More
Fri / Apr 20th
Epidiolex, a CBD-based pharmaceutical medication created by GW Pharmaceuticals in the United Kingdom, has received a unanimous recommendation from an FDA… Read More
Wed / Apr 11th
The Food and Drug Administration is asking for public comment on the international scheduling of cannabis following a request from… Read More
Mon / Mar 26th
The Massachusetts Alcoholic Beverage Control Commission will not allow a local brewer to move forward with plans to roll out… Read More
Wed / Mar 14th
MMJ Bioscience is in the process of securing orphan drug status from the U.S. Food & Drug Administration for MMJ… Read More
Mon / Sep 4th
The U.S. Food and Drug Administration (FDA) has put out a call for public comments regarding the therapeutic values and… Read More
Fri / May 26th
A new study published in the New England Journal of Medicine confirms what many patients, parents, advocates, and physicians already… Read More
Tue / Apr 4th OPINION
In my most recent publishing, I wrote that our hemp/CBD industry was being hijacked from us. “Us,” being those who… Read More
Wed / Feb 8th
It’s been nearly two months since mainstream media outlets and several cannabis publications published headlines claiming that the Drug Enforcement… Read More
Tue / Jan 24th
President Donald Trump has been announcing his nominations for the various positions in his administration since securing the election in… Read More
Website & branding by the Ganjapreneur in-house agency:
Uplifted cannabis industry branding & marketing.